Total Payments
$450,232
2024 Payments
$98,693
Companies
26
Transactions
313
Medicare Patients
140
Medicare Billing
$24,399
Payment Breakdown by Category
Consulting$224,922 (50.0%)
Travel$118,457 (26.3%)
Research$63,863 (14.2%)
Other$38,264 (8.5%)
Food & Beverage$4,691 (1.0%)
Education$34.62 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $224,922 | 105 | 50.0% |
| Travel and Lodging | $118,457 | 68 | 26.3% |
| Unspecified | $63,863 | 25 | 14.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $37,791 | 32 | 8.4% |
| Food and Beverage | $4,691 | 71 | 1.0% |
| Grant | $472.90 | 1 | 0.1% |
| Education | $34.62 | 11 | 0.0% |
Payments by Type
General
$386,369
288 transactions
Research
$63,863
25 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk AS | $158,365 | 71 | $0 (2024) |
| Boehringer Ingelheim International GmbH | $74,237 | 58 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $33,885 | 16 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $33,421 | 10 | $0 (2024) |
| Eli Lilly and Company | $26,572 | 39 | $0 (2024) |
| Lilly USA, LLC | $16,858 | 13 | $0 (2023) |
| Boehringer Ingelheim Pharma GmbH & Co.KG | $16,630 | 9 | $0 (2018) |
| AstraZeneca UK Limited | $16,597 | 11 | $0 (2024) |
| Kyowa Hakko Kirin Co., Ltd | $15,868 | 10 | $0 (2019) |
| Gilead Sciences, Inc. | $10,451 | 8 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $98,693 | 76 | Novo Nordisk AS ($79,083) |
| 2023 | $78,626 | 38 | Novo Nordisk AS ($37,517) |
| 2022 | $34,965 | 28 | Novo Nordisk AS ($17,795) |
| 2021 | $48,230 | 23 | Novo Nordisk AS ($15,640) |
| 2020 | $54,968 | 31 | AstraZeneca Pharmaceuticals LP ($13,388) |
| 2019 | $76,251 | 65 | Boehringer Ingelheim International GmbH ($17,816) |
| 2018 | $39,833 | 27 | Boehringer Ingelheim International GmbH ($17,092) |
| 2017 | $18,666 | 25 | Eli Lilly and Company ($10,764) |
All Payment Transactions
313 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $1,812.50 | General |
| 12/16/2024 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $1,450.00 | General |
| 12/16/2024 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $1,087.50 | General |
| 12/16/2024 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $725.00 | General |
| 12/16/2024 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $725.00 | General |
| 12/16/2024 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $725.00 | General |
| 12/13/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $59.35 | General |
| Category: Endocrinology | ||||||
| 12/05/2024 | Boehringer Ingelheim International GmbH | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $178.88 | General |
| 12/05/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $17.47 | General |
| Category: Insulin Pump | ||||||
| 11/15/2024 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 10/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: DIABETES | ||||||
| 10/24/2024 | Boehringer Ingelheim International GmbH | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $327.12 | General |
| 10/21/2024 | Novo Nordisk AS | — | Consulting Fee | Cash or cash equivalent | $1,125.00 | General |
| 10/21/2024 | Novo Nordisk AS | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 10/11/2024 | Boehringer Ingelheim International GmbH | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $81.37 | General |
| 09/30/2024 | Boehringer Ingelheim International GmbH | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $347.56 | General |
| 09/30/2024 | Boehringer Ingelheim International GmbH | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $140.57 | General |
| 09/17/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 09/17/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 09/17/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 09/10/2024 | Novo Nordisk AS | — | Travel and Lodging | In-kind items and services | $10,532.70 | General |
| 09/10/2024 | Novo Nordisk AS | — | Consulting Fee | Cash or cash equivalent | $5,718.75 | General |
| 09/10/2024 | Novo Nordisk AS | — | Travel and Lodging | In-kind items and services | $1,514.83 | General |
| 09/10/2024 | Novo Nordisk AS | — | Food and Beverage | In-kind items and services | $193.91 | General |
| 09/10/2024 | Novo Nordisk AS | — | Travel and Lodging | In-kind items and services | $175.59 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| NN9535-4321 | Novo Nordisk AS | $59,535 | 21 |
| NN9535-4662 | Novo Nordisk AS | $2,550 | 2 |
| TIRZEPATIDE STUDY OF RENAL FUNCTION IN PEOPLE WITH OVERWEIGHT OR OBESITY AND CHRONIC KIDNEY DISEASE WITH OR WITHOUT TYPE 2 DIABETES: FOCUS ON KIDNEY HYPOXIA IN RELATION TO FATTY KIDNEY DISEASE USING MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING | Eli Lilly and Company | $1,778 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 23 | 57 | $20,976 | $4,780 |
| 2022 | 1 | 29 | 61 | $20,801 | $5,351 |
| 2021 | 2 | 46 | 85 | $32,391 | $9,196 |
| 2020 | 2 | 42 | 56 | $17,564 | $5,072 |
Total Patients
140
Total Services
259
Medicare Billing
$24,399
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 57 | $20,976 | $4,780 | 22.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 61 | $20,801 | $5,351 | 25.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 27 | 53 | $17,543 | $5,311 | 30.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 19 | 32 | $14,848 | $3,885 | 26.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 19 | 29 | $10,382 | $3,280 | 31.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 23 | 27 | $7,182 | $1,791 | 24.9% |
About Dr. Katherine Tuttle, MD
Dr. Katherine Tuttle, MD is a Internal Medicine healthcare provider based in Spokane, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740399492.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Katherine Tuttle, MD has received a total of $450,232 in payments from pharmaceutical and medical device companies, with $98,693 received in 2024. These payments were reported across 313 transactions from 26 companies. The most common payment nature is "Consulting Fee" ($224,922).
As a Medicare-enrolled provider, Tuttle has provided services to 140 Medicare beneficiaries, totaling 259 services with total Medicare billing of $24,399. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology
- Location Spokane, WA
- Active Since 08/29/2006
- Last Updated 04/23/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1740399492
Products in Payments
- Ozempic (Drug) $57,197
- JARDIANCE (Drug) $39,158
- PRADAXA (Drug) $26,989
- TRULICITY (Drug) $15,993
- FARXIGA (Drug) $9,000
- PRAXBIND (Drug) $6,115
- TRADJENTA (Drug) $5,280
- Victoza (Drug) $3,165
- Non-Covered $2,610
- Non-Covered (Drug) $1,803
- Kerendia (Drug) $502.76
- INVOKANA (Drug) $129.62
- Veltassa (Drug) $84.72
- Korsuva (Drug) $66.10
- Korlym (Drug) $59.35
- Xolair (Biological) $53.27
- Rituxan (Biological) $49.40
- KRYSTEXXA (Biological) $43.04
- Wegovy (Drug) $25.28
- JESDUVROQ (Drug) $19.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Spokane
Jessica Craddock, Md, MD
Internal Medicine — Payments: $344,643
Internal Medicine $344,643
Dr. Radica Alicic, M.d, M.D
Internal Medicine — Payments: $50,393
Internal Medicine $50,393
James Mudd, M.d, M.D
Internal Medicine — Payments: $30,546
Internal Medicine $30,546
Dr. Rachel Safran, M.d, M.D
Internal Medicine — Payments: $17,911
Internal Medicine $17,911
Dr. Usman Ajaz, M.d, M.D
Internal Medicine — Payments: $9,648
Internal Medicine $9,648
Nishant Puri, Md, MD
Internal Medicine — Payments: $6,484
Internal Medicine $6,484